CIRM lures biotechs with $20M for stem cell teams

California's Institute of Regenerative medicine is planning to provide $20 million to each of 10 to 12 research teams that can be in the clinic with a new therapy inside of four years. Agency president Alan Trounson says that it's time to start moving stem cell work out of the lab and into human trials. Report

Suggested Articles

Loh joins the computational chemistry specialist after a two-year stint at Kymera Therapeutics.

The $3 billion funding boost includes an additional $350 million for targeted Alzheimer’s research.

Less than two years after taking the reins from founding chief Rusty Williams, Five Prime Therapeutics CEO Aron Knickerbocker is exiting the company.